Processing your payment...
Please do not close your browser.

Cancidas Market- Global Growth, Trends and Forecast (2022 - 2029) By Indication (Candidiasis, Thrush) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Regions

24 Jun, 2022 | 130 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Over the forecast period the Cancidas Market will register a CAGR 0.19 % in terms of revenue and the global Market size will reach USD in 498 Million by 2029.

Cancidas Market Overview

Cancidas is a lipopeptide antifungal medication developed by James Balkovec, Regina Black, and Frances A. Bouffard for Merck & Co., Inc. It belongs to the echinocandins, a novel class of antifungals. It acts by blocking the enzyme glucan synthase, which disrupts the fungal cell wall's integrity. The United States Food and Drug Administration authorized Cancidas as the first inhibitor of fungal glucan production.

Cancidas is injected into the vein. It has been shown to be useful in the treatment of Aspergillus and Candida species fungal infections. It belongs to the echinocandin family of antifungal medicines, which is a novel class of antifungal drugs having wide antifungal activity against all Candida species. In well-defined clinical contexts such as invasive Candida infections, Candida oesophagitis, and candidaemia, all three medicines in this class have been shown to be extremely effective or superior to therapy with fluconazole or Amphotericin B. Cancidas has been classified as class C since it has been proven in animal research to have embroyotoxic effects. Only if the benefit to the mother clearly outweighs the danger to the foetus should it be provided to pregnant women.

What is our Cancidas Market report scope?

 

Report Attributes

 

 

Report Details

 

Forecast Period 2022 to 2029

 

CAGR of 0.19 % during the review period (2022 to 2029).

 

By Indication

  • Candidiasis
  • Sub-clinical

 

 

By Distribution Channel

 

 

 

 

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

 

 

By Companies

  • Athenex, Inc.
  • Cipla Inc.
  • Fresenius SE & Co. KGaA (Fresenius Kabi)
  • Juno Pharmaceuticals (MDA Inc.)
  • Merck & Co., Inc.

 

 

Regions Covered

 

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

 

 

 

 

 

 

 

Countries Covered

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America

 

Historical Year

 

 

2017 to 2021

Forecast Year

 

2022 to 2029

Number of Pages

130

Who are the Major Players in Cancidas Market?

Market Growth Reports lists out all the Cancidas Market companies that are presently striving to reduce the impact of Covid-19 pandemic on the Market- Athenex, Inc., Cipla Inc., Fresenius SE & Co. KGaA (Fresenius Kabi), Juno Pharmaceuticals (MDA Inc.), Merck & Co., Inc., Others

Industry News:

Athenex Announces Recent Product Launches in 503B and Specialty Injectables Business Units

BUFFALO, N.Y., Feb. 13, 2018 - Athenex, Inc. a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced recent product launches from Athenex Pharmaceutical Division (“APD”). These launches highlight the continued portfolio growth with an emphasis on oncology or oncology supportive therapy, a business strategy of Athenex’s commercial business as an effective supplement to its progressing clinical pipeline focused on oncology.

What are the major Indication, Distribution Channel for Cancidas Market?

By Indication, it is segmented into

  • Candidiasis
  • Sub-clinical

By Distribution Channel it is segmented into

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Cancidas Market Regional Analysis

  • Throughout the projected period, North America is likely to lead the global Cancidas market. This dominance is mostly due to growing rates of vaginal, vulvovaginal, and fungemia candidiasis as a result of changing lifestyles and increased stress levels. Increased cases of candidemia and invasive aspergillosis in the United States due to a large geriatric population.
  • In addition, the market is fueled by an increase in antibiotic prescriptions and uncontrolled diabetes in the region. Over the projected period, the presence of important players and early product releases in the area are likely to contribute significantly to the growth of worldwide market revenue.
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East & Africa
    • Latin America
  1. INTRODUCTION
    • MARKET DEFINITION
    • MARKET DYNAMICS
    • MARKET SEGMENTATION
    • REPORT TIMELINES
    • KEY STAKEHOLDERS
  2. RESEARCH METHODOLOGY
    • DATA MINING
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
      • SUBJECT MATTER EXPERT ADVICE
    • QUALITY CHECK
    • FINAL REVIEW
      • DATA TRIANGULATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
      • RESEARCH FLOW
  3. EXECUTIVE SUMMARY
    • INTRODUCTION
    • GLOBAL CANCIDAS MARKET BY INDICATION
    • GLOBAL CANCIDAS MARKET BY DISTRIBUTION CHANNEL
  4. MARKET DYNAMICS
    • DRIVERS
      • INCREASING DEMAND FOR MSM SUPPLEMENT
    • RESTRAINTS
      • STRINGENT ENVIRONMENTAL REGULATIONS
      • HIGH COST OF MATERIALS
    • OPPORTUNITIES
      • CANCIDAS MARKET GROWTH
    • APPLICATION OF CANCIDAS MARKET IMPACT OF COVID 19
  5. GLOBAL CANCIDAS MARKET, BY INDICATION
    • INTRODUCTION
    • CANDIDIASIS
    • THRUSH
  6. GLOBAL CANCIDAS MARKET, BY DISTRIBUTION CHANNEL
    • INTRODUCTION
    • HOSPITAL PHARMACIES
    • RETAIL PHARMACIES
    • ONLINE PHARMACIES
    • OTHERS
  7. GLOBAL CANCIDAS MARKET, BY REGION
    • NORTH AMERICA
      • US
      • CANADA
      • MEXICO
    • EUROPE
      • GERMANY
      • FRANCE
      • UK
      • ITALY
      • RUSSIA
      • REST OF EUROPE
    • APAC
      • CHINA
      • SOUTH KOREA
      • JAPAN
      • INDIA
      • AUSTRALIA
      • ASEAN
      • REST OF APAC
    • MIDDLE EAST AND AFRICA
      • SAUDI ARABIA
      • UAE
      • SOUTH AFRICA
      • TURKEY
      • REST OF MEA
    • SOUTH AMERICA
      • BRAZIL
      • REST OF MEA
      • ARGENTINA
      • REST OF SOUTH AMERICA
  8. COMPETITIVE LANDSCAPE
    • MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,
    • AND AGREEMENTS
      • KEY DEVELOPMENT
    • MARKET SHARE PERCENT/RANKING ANALYSIS
    • STRATEGIES ADOPTED BY LEADING PLAYERS
  9. COMPANY PROFILES
    • BUSINESS OVERVIEW
    • COMPANY SNAPSHOT
    • PRODUCT BENCHMARKING
    • STRATEGIC INITIATIVES
      • ATHENEX, INC.
      • CIPLA INC.
      • FRESENIUS SE AND CO. KGAA (FRESENIUS KABI)
      • JUNO PHARMACEUTICALS (MDA INC.)
      • MERCK AND CO., INC.

 

 

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Request A Sample

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Korean Institute of Tuberculosis
  • Sanyo chemical Industries LTD
  • Novartis
  • Hisamitsu
  • Pfizer
  • AbbVie
  • RevHealth
  • Zeon Corporation
  • Abbott (Established Pharmaceutical Products)
  • Sinopharm (pharmaceutical distribution segment)
  • Takeda Pharmaceutical
  • Gilead Sciences
  • Sartorius
  • Zavation
  • Permobil
  • Ansell
  • Cefla